Search
Search Results
Found 9 items.
-
Treatment of very old patients with non valvular atrial fibrillation. The valuable opportunity offered by New Oral Anticoagulants, to be cautiously used
Published: December 30, 20131603PDF: 943 -
Direct oral anticoagulants in patients undergoing cardioversion: insight from randomized clinical trials
Published: May 18, 20172313PDF: 1146 -
Efficacy and safety of oral anticoagulant therapy in frail patients with atrial fibrillation
Published: June 7, 20184146PDF: 819 -
Thromboembolic and hemorrhagic risk stratification in patients with atrial fibrillation. Part I: the thromboembolic risk
Published: November 25, 20151056PDF: 692 -
Net clinical benefit of anticoagulation therapy in the elderly patients with atrial fibrillation
Published: June 7, 20183044PDF: 579 -
Thromboembolic and hemorrhagic risk stratification in patients with atrial fibrillation. Part II: hemorrhagic risk and guidelines recommendations
Published: November 25, 20151047PDF: 583 -
Rivaroxaban in non valvular atrial fibrillation: subgroups analysis
Published: August 19, 20151228PDF: 888 -
From warfarin to new oral anticoagulants in clinical practice. What is the future of anticoagulant therapy in atrial fibrillation?
Published: November 25, 2015736PDF: 657 -
Critical issues in megatrials on new oral anticoagulants. Rocket AF: applying results to low risk patients
Published: November 25, 2015974PDF: 621
1 - 9 of 9 items